Find a Condition by Name
Health & Wellness Information
Find a Doctor by Name
Departments & Divisions
Locations & Maps
Forms & Medical Records
Travel & Lodging
Becoming a Patient
Health & Wellness Tips
Patient Education & Support
Professional Education - CME/CE
Adult Clinical Trials
Pediatric Clinical Trials
See All Trials
Core Labs & Diagnostics
Tucker Medical Library
Gifts of Assets
Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
Researchers are conducting a study of how human blood cells work. Their goal is to examine how these cells respond to different bacteria and other foreign substances.
Idiopathic pulmonary fibrosis (IPF) currently affects millions of people globally, and current treatments such as pirfenidone or nintedanib are often poorly tolerated in some patients due to frequently associated side effects. Researchers want to know if an investigational medication called BBT...
The UNISUS study will compare the effectiveness and safety of a higher dose of an investigational medication called Opsumit to a lower dose in people with pulmonary arterial hypertension (PAH). The results of the UNISUS Study will provide more information about the investigational medication’s...
The goal of this study is to develop ways for health care providers to educate men with CF about infertility and to identify ways for men with CF to integrate care for their reproductive health into their daily routines.
Many people returning from military deployment have developed asthma as a result of inhaling hazardous materials. Exposures to diesel, burn pits, biomass smoke and sandstorms during deployment likely play a role. Some people with deployment-related asthma do not respond well to standard asthma...
Continuous scarring (fibrosis) can gradually impair lung function, leading to breathing difficulties. Researchers are examining whether an investigational medication called BI 1015550 can help adults aged 18 and older with progressive lung diseases with fibrosis.
For many people living with cystic fibrosis, there are treatments available called cystic fibrosis transmembrane conductance regulator (CFTR) modulators that can help treat the underlying cause of cystic fibrosis. However, more than 5,000 people living with cystic fibrosis have a change in both...
People with severe asthma are often dependent on oral corticosteroids, such as prednisone, to treat their condition. Researchers are currently investigating whether a new biologic treatment called tezepelumab may help to reduce or remove the need for these steroid medications.
Eczema (atopic dermatitis) is typically classified as mild, moderate or severe. In this trial, researchers are studying gene expression for the varying severity levels of eczema in order to guide new and improved treatments strategies and more personalized treatments.
Determine the efficacy and safety of lurbinectedin (a type of chemotherapy) when combined with atezolizumab (an immunotherapy treatment) as a maintenance treatment for those with ES-SCLC.
Researchers want to know if an investigational medication can reduce the number of exacerbations in people with chronic obstructive pulmonary disease (COPD).
The RESOLVE-Lung study is evaluating the safety and effectiveness of the investigational medicine namilumab for the treatment of pulmonary sarcoidosis.
Researchers are studying a new medication called PRA023 that has anti-inflammatory and antifibrotic properties to determine how well it works against systemic sclerosis (SSc) with interstitial lung disease (ILD).
To help better understand adrenal insufficiency (AI) and its progression, researchers have developed a new registry called MyAI.
The IPF COMFORT Study is a clinical research study in patients with coughing attributed to Idiopathic Pulmonary Fibrosis.
Researchers want to understand how the body of a person with active lung cancer responds to
COVID-19, should they contract the virus.
Researchers want to know if a small experimental device called Breathe Away is safe and effective. The device (the size of a large cell phone) gathers information from a pulse oximeter, which is worn on the ear of the participant.
Researchers want to learn if a blood test can be used to identify cancers in adults. Current or former smokers who have been diagnosed with cancer but haven’t started treatment are needed for this trial. Participants will receive a blood draw and review of their medical history with a research...
People with eosinophilic granulomatosis with polyangiitis (EGPA) are needed for the OCEAN clinical trial. The study compares two medications: mepolizumab (NUCALA), which is administered by an injection once a month, and depemokimab, an investigational medication that is injected twice a year.
Adults with Cystic Fibrosis who are unable to take CFTR modulators are being asked to participate in a clinical trial for an investigational gene therapy drug known as 4D-710.
Researchers are asking healthy adults, 25-35 years old, to join a five-year study exploring factors that may affect lung health with the goal of understanding lung disease.
Researchers want to determine if a possible new inhaled therapy, AR-501, is a safe and effective treatment for Pseudomonas infections in adults with cystic fibrosis.
If you are a pregnant with cystic fibrosis, consider participating in this trial to learn how pregnancy affects your health.
This exercise study is investigating how an already FDA approved drug for treatment of pulmonary vascular disease, sildenafil (Revatio ®), impacts exercise tolerance and capacity in people with cystic fibrosis (CF).
The purpose of this study is to collect data on what drives asthma in the body and how it reacts depending on the environment and treatment.
Researchers are developing a way to predict asthma attacks in adults with severe, difficult-to-treat asthma by collecting data while they sleep.
Can allergies be prevented in infants? Researchers want to know if keeping a baby’s skin healthy and hydrated with moisturizer will prevent the child from developing allergies such as food allergies. Learn how you and your child can help researchers.
National Jewish Health researchers are studying the antibody response to COVID-19 vaccines in people with chronic conditions.
Researchers are working to understand the different ways sarcoidosis, a disease that causes scarring in the lungs, develops.
Researchers want to better understand if the causes of asthma, eczema, food allergies, eosinophilic esophagitis and GERD can be determined at a cellular level.
Researchers want to find new measures of asthma control by tracking each participant’s asthma symptoms and response to omalizumab, while collecting data with a FitBit® and smartphone.
Can frequent video calls with a pharmacist via smart phone or computer help 14-30-year-olds take their prescribed asthma medications regularly and have fewer asthma symptoms?
Are biomarkers in the blood of patients with hypersensitivity pneumonitis (HP) predictive? Researchers understand if biomarkers can help doctors understand how quickly the disease will progress
Studies have shown that weight loss can improve heart function. Researchers want to see if a ketogenic diet is an effective treatment for heart failure with preserved ejection fraction.
Why do babies develop food allergies and eczema? Researchers are studying factors before birth and through age 3 that may influence the development of allergic conditions.
Researchers want to improve medical care for asthmatics with new mobile health technologies. Study participants will use at-home technologies to track and record health data and participate in surveys and questionnaires about their health.
Adults with cancer who are receiving immunotherapy are needed for a new research study to understand how immunotherapy changes the body’s immune response leading to skin reactions.
Researchers want to see if a new drug, alvelestat, improves the symptoms of lung disease caused by COPD due to alpha-1 antitrypsin deficiency (AATD), as well as symptoms of AATD.
Researchers are studying the differences in the skin and immune cells of people with food allergies and eczema, and those without.
Researchers want to know if a new medication, Saracatinib, is a more safe and effective treatment for Idiopathic Pulmonary Fibrosis (IPF) when compared to treatments that are currently available.
Researchers want to know what causes food allergies, eczema and wheezing in infants. If you’re pregnant, you may be able to help find the answer.
If you have uncontrolled asthma you may qualify for a study to help researchers understand how to treat different types of severe asthma using precision medicine.
Patients with medically inoperable stage I/IIA non-small cell lung cancer (NSCLC) who have not received prior anticancer therapy for lung cancer, may qualify for a clinical trial investigating if the combination of pembrolizumab (MK-3475) and Stereotactic Body Radiation Therapy (SBRT) may help...
If you’ve been exposed to silica dust, like stone and concrete, you may have developed a silica-related disease. National Jewish Health is creating a registry for silicosis and related diseases in order to better understand their risk factors and prevention.
National Jewish Health researchers want to understand what people with COPD know about their disease.
Anyone with hypersensitivity pneumonitis may qualify for this observational study and help researchers find patterns for predicting ILD.
National Jewish Health researchers are trying to determine why people with atopic dermatitis or eczema are more susceptible to bacterial infections. Learn how you can participate in our research study.
Our researchers are working to identify the clinical, physiologic, genetic and molecular characteristics of asthmatics.
By adding a new investigational Pulmonary Arterial Hypertension (PAH) medication to your current therapy, you could experience relaxed and widened artery walls.
By participating in our study, you can help forward research on lung disease. Our researchers are hoping to learn more about the blood cells involved in the development of scarring lung diseases and create new treatment therapies.
The purpose of this study is to learn more about lung disease found in contractors and U.S. military personnel serving in Iraq and Afghanistan after September 11, 2001.
Our researchers are trying to understand the connection, as well as how to prevent and treat lung disease in RA patients.
Our researchers are trying to understand how interstitial lung disease (ILD) develops in people with rheumatoid arthritis (RA), and how it may impact their quality of life.
The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).
If you are an adult with sarcoidosis who is not on immunosuppressive therapy, you may be able to help our researchers learn more about different types of sarcoidosis and how it develops.
Our researchers are studying lung diseases that develop from inhaling mineral dust over time. Although the cause of diseases such as "black lung" are known, it is not well understood why some people develop these diseases and others don't.
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.
Adults with cystic fibrosis (CF) are at a higher risk of developing colon cancer due to a mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) gene..